Try our Advanced Search for more refined results

October 24, 2016

Onyx Therapeutics, Inc. v. CIPLA Limited et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. May 05, 2020

    Amgen Comes Out On Top After Bench Trial Over Cancer Drug

    Amgen Inc. may have staved off generic competition for its injectable anti-cancer drug Kyprolis for another seven years, after a Delaware federal judge refused to declare a trio of patents tied to the drug invalid.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login